Koen Chiers

Prof. Dr. Koen Chiers

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2010 in Veterinary Research
Verified
Journal Article
Open access
PDF file
KCKoen Chiers
Koen Chiers
TWTine De Waele
Tine De Waele
FPFrank Pasmans
Frank Pasmans
RDRichard Ducatelle
Richard Ducatelle
FHFreddy Haesebrouck
Freddy Haesebrouck
Actinobacillus pleuropneumoniae is the causative agent of porcine pleuropneumonia. The virulence factors of this microorganism involved in colonization and the induction of lung lesions have been thoroughly studied and some have been well characterized. A. pleuropneumoniae binds preferentially to cells of the lower respiratory tract in a process involving different adhesins and probably biofilm formation. Apx toxins and lipopolysaccharides exert pathogenic effects on several host cells, resulting in typical lung lesions. Lysis of host cells is essential for the bacterium to obtain nutrients from the environment and A. pleuropneumoniae has developed several uptake mechanisms for these nutrients. In addition to persistence in lung lesions, colonization of the upper respiratory tract – and of the tonsils in particular – may also be important for long-term persistent asymptomatic infection. Information on virulence factors involved in tonsillar and nasal cavity colonization and persistence is scarce, but it can be speculated that similar features as demonstrated for the lung may play a role.

1 April 2002 in Veterinary Microbiology
Verified
Journal Article
Closed access
KCKoen Chiers
Koen Chiers
EDEef Donné
Eef Donné
IOIngrid Van Overbeke
Ingrid Van Overbeke
RDRichard Ducatelle
Richard Ducatelle
FHFreddy Haesebrouck
Freddy Haesebrouck

25 June 2018 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
TMT. Martinello
T. Martinello
CGChiara Gomiero
Chiara Gomiero
APAnna Perazzi
Anna Perazzi
IIIlaria Iacopetti
Ilaria Iacopetti
FGF. Gemignani
F. Gemignani
MPMarco Patruno
Marco Patruno
Skin wound healing includes a system of biological processes, collectively restoring the integrity of the skin after injury. Healing by second intention refers to repair of large and deep wounds where the tissue edges cannot be approximated and substantial scarring is often observed. The objective of this study was to evaluate the effects of mesenchymal stem cells (MSCs) in second intention healing using a surgical wound model in sheep. MSCs are known to contribute to the inflammatory, proliferative, and remodeling phases of the skin regeneration process in rodent models, but data are lacking for large animal models. This study used three different approaches (clinical, histopathological, and molecular analysis) to assess the putative action of allogeneic MSCs at 15 and 42 days after lesion creation. At 15 days post-lesion, the wounds treated with MSCs showed a higher degree of wound closure, a higher percentage of re-epithelialization, proliferation, neovascularization and increased contraction in comparison to a control group. At 42 days, the wounds treated with MSCs had more mature and denser cutaneous adnexa compared to the control group. The MSCs-treated group showed an absence of inflammation and expression of CD3+ and CD20+. Moreover, the mRNA expression of hair-keratine (hKER) was observed in the MSCs-treated group 15 days after wound creation and had increased significantly by 42 days post-wound creation. Collagen1 gene (Col1α1) expression was also greater in the MSCs-treated group compared to the control group at both days 15 and 42. Peripheral blood-derived MSCs may improve the quality of wound healing both for superficial injuries and deep lesions. MSCs did not induce an inflammatory response and accelerated the appearance of granulation tissue, neovascularization, structural proteins, and skin adnexa.

8 September 2011 in Cellular Microbiology
Verified
Journal Article
Open access
PDF file
BFBram Flahou
Bram Flahou
FHFreddy Haesebrouck
Freddy Haesebrouck
KCKoen Chiers
Koen Chiers
KDKim Van Deun
Kim Van Deun
LSLina De Smet
Lina De Smet
RDRichard Ducatelle
Richard Ducatelle
Helicobacter (H.) suis is the most prevalent non-H. pylori Helicobacter species colonizing the stomach of humans suffering from gastric disease. In the present study, we aimed to unravel the mechanism used by H. suis to induce gastric epithelial cell damage. H. suis lysate induced mainly apoptotic death of human gastric epithelial cells. Inhibition of γ-glutamyl transpeptidase (GGT) activity present in H. suis lysate and incubation of AGS cells with purified native and recombinant H. suis GGT showed that this enzyme was partly responsible for the observed apoptosis. Supplementation of H. suis or H. pylori GGT-treated cells with glutathione strongly enhanced the harmful effect of both enzymes and resulted in the induction of oncosis/necrosis, demonstrating that H. suis and H. pylori GGT-mediated degradation of glutathione and the resulting formation of glutathione degradation products play a direct and active role in the induction of gastric epithelial cell death. This was preceded by an increase of extracellular H2O2 concentrations, generated in a cell-independent manner and causing lipid peroxidation. In conclusion, H. suis and H. pylori GGT-mediated generation of pro-oxidant glutathione degradation products brings on cell damage and causes apoptosis or necrosis, dependent on the amount of extracellular glutathione available as a GGT substrate.

6 September 2001 in Veterinary Microbiology
Verified
Journal Article
Closed access
KCKoen Chiers
Koen Chiers
IOIngrid Van Overbeke
Ingrid Van Overbeke
EDEef Donné
Eef Donné
MBMargo Baele
Margo Baele
RDRichard Ducatelle
Richard Ducatelle
FHFreddy Haesebrouck
Freddy Haesebrouck

28 March 2023 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Open access
ETEmily Taillieu
Emily Taillieu
CWChloë De Witte
Chloë De Witte
HSHeiko De Schepper
Heiko De Schepper
WMWouter Van Moerkercke
Wouter Van Moerkercke
SRSophie Rutten
Sophie Rutten
CSChristophe Van Steenkiste
Christophe Van Steenkiste
Summary: Background: Gastric non‐Helicobacter pylori Helicobacter (NHPH) species naturally associated with animals have been linked with gastric disease in human patients.Aim: The prevalence and clinical significance of zoonotic gastric NHPHs was determined in large and well‐defined, H. pylori‐negative, gastric patient populations.Methods: Patients were retrospectively (n = 464) and prospectively (n = 65) included for gastric biopsy collection: chronic gastritis (CG), peptic ulcer disease and gastric MALT lymphoma, without identified aetiology. PCR and sequencing was performed for the detection of gastric Helicobacter species. Retrospectively, asymptomatic gastric bypass patients (n = 38) were included as controls. Prospectively, additional saliva samples and symptom and risk factor questionnaires were collected. In this group, patients with gastric NHPH infection were administered standard H. pylori eradication therapy and underwent follow‐up gastroscopy post‐therapy.Results: In the retrospective samples, the prevalence of gastric NHPHs was 29.1%, while no gastric NHPHs were detected in control biopsies. In the prospective cohort, a similar proportion tested positive: 27.7% in gastric tissue and 20.6% in saliva. The sensitivity and accuracy for the detection of gastric NHPHs in saliva compared to gastric tissue was 27.8% and 69.8% respectively. Following eradication therapy, clinical remission was registered in 12 of 17 patients, histological remission in seven of nine and eradication in four of eight patients.Conclusion: These findings suggest a pathophysiological involvement of NHPHs in gastric disease. Patients presenting with gastric complaints may benefit from routine PCR testing for zoonotic gastric NHPHs.